Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:chemicalFormula |
C20H25N3O2S
|
| gptkbp:compatibleWith |
75%
|
| gptkbp:current_use |
treatment of depression
|
| gptkbp:established |
gptkb:XYZ_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
WPC-990
|
| gptkbp:impact |
dizziness
nausea dry mouth |
| gptkbp:is_used_in |
pharmaceutical research
|
| gptkbp:isATypeOf |
123456-78-9
|
| gptkbp:operational_status |
clinical trials
|
| gptkbp:origin |
N-(4-(4-(dimethylamino)phenyl)-1,3-thiazol-2-yl)-2-(4-methylphenyl)propan-2-amine
|
| gptkbp:route |
oral
|
| gptkbp:targets |
serotonin receptors
|
| gptkbp:weight |
373.55 g/mol
|